Avalo Therapeutics Inc【AVTX】 資本金及び資本剰余金の推移

機能の使い方
(単位:千ドル) 資本金及び資本剰余金 前年比(%)
1Q25 506,027 +47.2%
4Q24 503,295 +47.0%
3Q24 356,000 +4.2%
2Q24 344,353 +9.4%
1Q24 343,882 +11.8%
4Q23 342,438 +16.9%
3Q23 341,661 +17.0%
2Q23 314,769 +8.1%
1Q23 307,512 +5.8%
4Q22 292,918 +2.7%
3Q22 291,984 +3.1%
2Q22 291,253 +17.8%
1Q22 290,560 +20.3%
4Q21 285,248 +41.0%
3Q21 283,279 +41.1%
2Q21 247,163 +24.0%
1Q21 241,624 +50.1%
4Q20 202,351 +49.6%
3Q20 200,713 +49.6%
2Q20 199,265 +53.8%
1Q20 160,995 +25.0%
4Q19 135,283 +13.6%
3Q19 134,130 +19.6%
2Q19 129,588 +48.5%
1Q19 128,789 +53.4%
4Q18 119,122 +42.9%
3Q18 112,167 +45.3%
2Q18 87,274 +13.4%
1Q18 83,975 +17.3%
4Q17 83,369 +18.7%
3Q17 77,193 +11.9%
2Q17 76,929 +13.5%
1Q17 71,569 +5.9%
4Q16 70,242 +5.4%
3Q16 68,983 +304.3%
2Q16 67,798 -
1Q16 67,584 -
4Q15 66,647 -
3Q15 17,063 -